Aeon aggregates multi-modal health data—MRI imaging, blood markers, genetic profiles—into a single longitudinal platform with embedded AI modeling for early detection and preventive care. The company is actively scaling its product function while navigating regulatory pathways toward formal medical device certification, a constraint visible in their pain-point list. Hiring velocity is accelerating with a C-level product leader and mid-to-senior engineers focused on data/AI infrastructure and customer-facing health modules.
Notable leadership hires: Chief Product Officer
Aeon is a Swiss health-tech startup founded in 2023 that operates a whole-body health platform combining advanced screening—MRI, blood biomarkers, genetics—with AI-powered analysis to enable continuous health monitoring and early disease detection. The platform surfaces longitudinal health insights to individuals and integrates with medical partner labs via a dedicated provider portal. Product strategy centers on accessibility: reducing friction in medical data interpretation for non-experts, optimizing booking and decision flows, and building ecosystem touchpoints (health dashboard, rituals, feature modules). The company is in active product scaling and establishing regulatory foundations for medical device classification.
Aeon integrates MRI, blood markers, genetics, and other biomarkers into a single health platform with AI diagnostics for early detection and longitudinal health monitoring. The platform serves individuals directly and connects to medical partner labs.
Aeon is building its regulatory foundation from scratch and moving toward formal medical device certification, a visible constraint in their current pain-point and project roadmaps.